Showing results (741-750 of 1,088) with videos related to

Sort By:
Pageof 109
Immunity|August 23, 2003
Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding proteinJoerg R Weber, Dorette Freyer, Christian Alexander, et al.
Pain Medicine (Malden, Mass.)|January 27, 2021
Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical TrialRichard D Berkowitz, Richard Steinfeld, Alexander P Sah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2025
Behind closed doors: a qualitative study exploring the content of fertility discussions between oncologists and their adolescent and young adult cancer patients from the perspective of oncologists at an NCI-designated comprehensive cancer centerJulia Stal, Charleen I Roche, Serena Y Yi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 18, 2001
Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegenerationC Harms, M Lautenschlager, A Bergk, et al.
Pediatric Blood & Cancer|February 1, 2014
Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiationRajkumar Venkatramani, Sunil Kamath, Kenneth Wong, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 16, 2007
[Improvement of medical care by supporting the intention to change health risk behavior]Ulrich John, Christian Meyer, Sabina Ulbricht, et al.
Breast Cancer Research and Treatment|November 21, 2008
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO studyC Falandry, M Debled, T Bachelot, et al.
Cancers|December 10, 2021
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate CancerDenis Maillet, Nathalie Allioli, Julien Péron, et al.
Cancer|April 11, 2016
Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology GroupJoann L Ater, Caihong Xia, Claire M Mazewski, et al.
The Oncologist|May 6, 2022
Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based ClinicsElizabeth J Siembida, Holli A Loomans-Kropp, Irene Tami-Maury, et al.
Pageof 109